Welcome to DU! The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards. Join the community: Create a free account Support DU (and get rid of ads!): Become a Star Member Latest Breaking News General Discussion The DU Lounge All Forums Issue Forums Culture Forums Alliance Forums Region Forums Support Forums Help & Search


(16,254 posts)
Sun Jul 2, 2017, 12:44 PM Jul 2017

Damn it,we need a fact-based debate...WHERE the money GOES, not just who to KICK OUT of lifeboat?

In this stupid debate about who should or shouldn't be thrown out of the lifeboat, about who pays for the bloated bureaucratic behemoth we call the "US Healthcare System", can we talk about health care costs?

Pharma Revenues by Market

US $339 B
Japan $94 B
China. $87 B
Germany $46 B
France. $37 B
Italy. $27 B
Britain. $24 B

Partly driven by excess marketing, absurd "what the market will bear" pricing, markets for prescriptions expanded by lobbying the AMA or NIH to drop targets for blood pressure or diabetes etc., and kickbacks to doctors.

That's just pharma. So, what happens if we focus on where the money is going? Might pharmaceutical revenues be under threat? Could it be that our public discussion is restricted to "Single Payer vs. ACA vs. Tax Credits vs. Cutting Medicaid" because focus on underlying costs would create downward pressure on revenue for major health related corporations?

One minor difference between the U.S. And other countries is gunshot wounds -- likely exceeding $3.7 billion per year. ($1.4 / 42% + $180 + $224)

From Blue Cross Website, 39% hospitals; 22% physician/clinic, 21% pharma, 10% administration.

Or this, broken down by disease.

Breakdown of hospital stays: https://www.hcup-us.ahrq.gov/reports/statbriefs/sb148.jsp
Interesting collection of public health references: http://www.bettycjung.net/Phdata2.htm

Here's a hypothesis: The RANGE of DEBATE on this topic has been ARTIFICIALLY and intentionally NARROWED to prevent real debate. Real debate might cause us to take steps like: banning direct-to-consumer ads, outlawing price differentials based on who pays for a procedure or drug, identifying the most wasteful and ineffective drugs, prohibiting price gouging. What we humans see as "savings" is seen by WallStreet (and its most important owners) as drops in revenue. The impact on market cap is the bitter pill that the Owners refuse to swallow.

They'd rather kill Medicaid and eventually Medicare, and force old or sick people to use their life savings and reverse mortgages to cope with inflated costs, than accept a present decline in Pfizer or Untied HealthCare or Merck or Aetna stock. That's a big part of the reason that common sense is swimming upstream in American politics. Protecting the Dow.

4 replies = new reply since forum marked as read
Highlight: NoneDon't highlight anything 5 newestHighlight 5 most recent replies
Damn it,we need a fact-based debate...WHERE the money GOES, not just who to KICK OUT of lifeboat? (Original Post) lostnfound Jul 2017 OP
Yes yes yes. NT enough Jul 2017 #1
THIS is the problem. Why do we spend so much MORE per capita? Needs extensive analysis. lostnfound Jul 2017 #2
The absurdity of thinking that dropping people out is better than tackling the gap in costs lostnfound Jul 2017 #3
Dividends. Examples. lostnfound Jul 2017 #4


(16,254 posts)
3. The absurdity of thinking that dropping people out is better than tackling the gap in costs
Sun Jul 2, 2017, 05:17 PM
Jul 2017

All that excess is going somewhere. My estimate based on. 2.35% dividend yield (TTM per Fidelity analysis) on the health sector which totals $4.77 Trillion in market cap is that $112 Billion in dividends are being paid. A estimate on the high side perhaps because there's been some growth in market cap over the last year but it's a ballpark.


(16,254 posts)
4. Dividends. Examples.
Sun Jul 2, 2017, 07:58 PM
Jul 2017

First 3 columns of data are from http://www.dividend.com/dividend-stocks/healthcare/
Last column is from annual reportt

company yield% share dividend. Dividend 2016
Johnson&J 2.54% $132.29 $3.3. $8.6 B (PLUS $7 B stock buyback)
Pfizer 3.81% $33.59 $1.28 $7.4 B
UnitedHealth 1.62% $185.42 $3.00 $2.26 B
Aetna 1.32% $151.83 $2.00 $

Latest Discussions»General Discussion»Damn it,we need a fact-ba...